
Home Blood Pressure Monitoring Project
HypertensionThe goal of this project is to improve hypertension control at Kaiser Permanente Colorado (KPCO) by implementing a population-based multi-factorial intervention that uses home BP monitors that can download BP readings to KPCO's health records via internet, interactive voice response (IVR) technology, and multidisciplinary care team. Participants will be randomized to either the home blood pressure monitoring group receiving the multi-factorial intervention or the usual care group who will be receiving Kaiser standard of care. We will determine the proportion of patients in each group who achieve their target BP goals at 6 months, according to national clinical practice guidelines. The study hypothesis is that a higher proportion of patients with uncontrolled hypertension in the home blood pressure monitoring (HBPM) group will achieve their target blood pressure compared to those in the usual care (UC) group.

Sodium Excretion of LCZ696 in Patients With Hypertension; Heart Failure and Healthy Volunteers
HypertensionAssess mechanism of action of LCZ696 related to sodium excretion.

A Study of Single Dose MK-3614 (MK-3614-001)(COMPLETED)
HypertensionThis study will determine if MK-3614, given as single doses, is safe and well tolerated in healthy males and male participants with mild to moderate hypertension.

Effects of Anthocyans on Cardiovascular and Sympathetic Function
HypertensionAnthocyans modify cardiovascular and sympathetic function

VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With Microalbuminuria...
HypertensionThe purpose of this study is to compare if the combination of valsartan 320 mg/lisinopril 20 mg versus the monotherapies of lisinopril 40 mg or valsartan 320 mg will result in a greater decrease of urinary albumin excretion measured as urinary albumin/creatinine ratio (UACR) in the first morning urine of hypertensive subjects with previously diagnosed microalbuminuria (MAU).

Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension...
HypertensionThis is a double-blind study to evaluate the reduction in systolic blood pressure using a therapy initiated with valsartan 160 mg or valsartan + hydrochlorothiazide (HCTZ) 160/12.5 mg compared to a more conventional approach (therapy initiated with low-dose valsartan 80 mg).

Improving Adherence to Blood Pressure Guidelines
HypertensionThe purpose of this study is to evaluate the impact of physician/pharmacist collaborative teams on hypertension guideline adherence for patients with uncontrolled hypertension in six family medicine practice sites in Iowa.

Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface Health
Open Angle GlaucomaOcular HypertensionThe purpose of this study is to understand differences in visual function-related patient-reported outcomes between a non-BAK medication (Travoprost APS) and a BAK-preserved medication (XALATAN®) in patients with open-angle glaucoma or ocular hypertension.

To Demonstrate the Relative Bioavailability of Atenolol Tablets
HypertensionTo demonstrate the relative bioavailability of Atenolol tablets.

A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups...
HypertensionThe initial 12 week portion of this 20 week study will examine the ability of a combination of olmesartan medoxomil and amlodipine to lower the blood pressure of patients with high blood pressure who have not had sufficient blood pressure reduction using one anti-hypertension drug (monotherapy). The final 8 weeks of this 20 week study will examine the ability of a combination of olmesartan medoxomil, amlodipine and hydrochlorothiazide to lower blood pressure in the same patient population. All three medications being tested have been approved by the FDA for the treatment of high blood pressure, but only amlodipine and olmesartan are currently approved for use in combination form.